The Asia Pacific Nasal Cannula Market would witness market growth of 4.6% CAGR during the forecast period (2021-2027).
A nasal cannula is also used by pilots and passengers especially in small, unpressurized aircraft that do not surpass specific altitudes. The cannula is helpful in providing supplementary oxygen to pilots and passengers to compensate for the lower oxygen content at the low ambient air pressures at higher altitudes. Thus, it prevents the arousal of hypoxia condition. Moreover, specialized aviation cannula systems are made for this purpose.
The demand and adoption of the nasal cannula are constantly growing due to the growing number of manufacturers and suppliers across the globe. The major players of the market have a broad distribution network that enhances the availability of products that are highly technologically advanced. Nowadays silicone materials are used in manufacturing nasal cannula that is latex-free, extra soft, curved, and flared cannulas. These properties improve the comfort and flexibility of the product. The increasing adoption of the nasal cannula in the treatment of chronic respiratory disease has further expanded the usage of the nasal cannula in patients of almost all age groups. Moreover, the rising e-commerce channels have also augmented the availability of products across the globe. It is increasingly used in-home care settings that further drive the adoption of the nasal cannula. All these factors are likely to boost market growth during the forecast period.
The market for nasal cannula in the Asia Pacific is witnessing considerable growth in recent years. It is due to the massive population and growing smoking prevalence leading to the increased incidences of respiratory diseases in emerging nations like India, China, and others. In addition, healthcare infrastructure is also improving in developing counties along with the adoption of technologically advanced healthcare products. The rising geriatric population, increasing occurrence of respiratory diseases, and growing healthcare expenditure in the emerging countries are the major factors boosting the growth of the nasal market in this region. The expansion is largely due to degraded air quality, increasing population, and growing prevalence of smoking resulting in increased respiratory ailment instances.
The China market dominated the Asia Pacific High Flow Nasal Cannula Market by Country in 2020, thereby, achieving a market value of $171.8 million by 2027. The Japan market is showcasing a CAGR of 5% during (2021-2027). Additionally, The India market is anticipated to witness a CAGR of 5% during (2021-2027).
Based on Material, the market is segmented into Plastic and Silicone. Based on End Use, the market is segmented into Hospitals, Long Term Care Centers, Ambulatory Healthcare Services, and Other End Uses. Based on Type, the market is segmented into Low Flow Nasal Cannula and High Flow Nasal Cannula. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Nasal Cannula Market is Projected to reach USD 7.9 Billion by 2027, at a CAGR of 4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allied Healthcare Products, Inc., Besmed Health Business Corporation, ResMed, Inc., Teleflex, Inc., Medical Depot, Inc. (Drive DeVilbiss Healthcare), Fairmont Medical Products Pty. Ltd., Fisher and Paykel Healthcare Limited, Sunset Healthcare Solutions, Inc., Smiths Group PLC, and Flexicare Medical Ltd.
By Material
By End Use
By Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 